Antiplatelet agents for stroke patients

MeReC Bulletin

Volumn 14, Issue 2, 2003, Pages 5-8

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; MISOPROSTOL; PROTON PUMP INHIBITOR; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRONCHOSPASM; CEREBROVASCULAR ACCIDENT; CONSTIPATION; CONTROLLED RELEASE FORMULATION; DIARRHEA; DIGESTIVE SYSTEM ULCER; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG RELEASE; DRUG TOLERABILITY; DRUG USE; DYSPEPSIA; ENTERIC COATED TABLET; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; HYPOTENSION; INDIGESTION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LOW DRUG DOSE; MEDICAL DECISION MAKING; MITRAL VALVE DISEASE; NAUSEA AND VOMITING; PATIENT CARE; RASH; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; SECONDARY PREVENTION; STOMACH INJURY; STROKE; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE;

EID: 0141519192     PISSN: 14655659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. National Service Framework for Older People. London: Department of Health; 2001. Available from: URL: http//www.doh.gov.uk/nsf/
2. Hankey GJ, Warlow CP. Treatment and secondary prevention of stroke: evidence, cost, and effects on individuals and populations. Lancet 1999;354:1457-63.
3. Rothwell PM. The high cost of not funding stroke research: a comparison with heart disease and cancer. Lancet 2001;357-1612-6.
4. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
5. Management soon after a stroke. Drug Ther Bull 198;36:51-4.
6. Lip GYH, Kamath S, Hart RG. ABC of antithrombotic therapy: antithrombotic therapy for cerebrovascular disorders. BMJ 2002;325:1161-3.
7. Clinical Evidence writers on stroke prevention. Stroke prevention. In: Barton S, editor. Clinical Evidence, Issue 9. London: BMJ Publishing Group;2003:221-45.
8. Barnett HJM, Eliasziw M, Meldrum HE. Evidence based cardiology: prevention of ischaemic stroke. BMJ 1999;318:1539-43.
9. Gubitz G, Sandercock P. Prevention of ischaemic stroke. BMJ 2000;321:1455-9.
10. Royal College of Physicians. National clinical guidelines for stroke: update 2002. London: The College; 2002. Available from: URL: http://www.rcplondon.ac.uk/pubs/books/stroke. Accessed 19-08-03.
11. Scottish Intercollegiate Guidelines Network. Antithrombotic therapy (No. 36). Edinburgh: SIGN; 1999. Available from: URL: http://www.sign.ac.uk/guidelines/fulltext/36/index.html. Accessed 19/08/03.
12. Koudstaal PJ. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attacks (Cochrane Review). In : The Cochrane Library, Issue 1, 2003. Oxford: Update Software.
13. Powers WJ. Oral anticoagulant therapy for the prevention of stoke [Editorial]. N Engl J Med 2001;345:1493-5.
14. The New GP Contract: Quality and outcomes framework guidance. Available from: URL: http://www.bma.org.uk/ap.nsf/Content/QualityOutcomes. Accessed 01/08/03.
15. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
16. National Institute for Clinical Excellence, Scope: clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events. February 2003. Available from: URL: http://www.nice.org.uk/article.asp?a=66245. Accessed 01/07/03.
17. Sowerby Centre for Health Informatics at Newcastle. Transient ischaemic attact - not in atrial fibrillation. PRODIGY; 2002. Available from: URL: http://www.prodigy.nhs.uk. Accessed 19/08/03.
18. British National Formulary, No. 45. London: British Medical Association/Royal Pharmaceutical Society of Great Britain; 2003.
19. National Prescribing Centre. NSAIDs and gastroprotecton/Cox-II selective inhibitors. MeRec Briefing. October 2002. No.20. Available from: URL: http://www.npc.co.uk/MeReC_Briefings/briefing2002.htm.
20. Diener HC, Cunha L, Forbes C, et al. European stroke prevention study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.
21. Wilterdink JL, Easton JD. Dipyridamole plus aspirin in cerebrovascular Arch Neurol 1999;56:1087-92.
22. De Schryver ELLM, Algra A, van Gijn J. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
23. CAPRIE steering committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1993;348:1329-39.
24. The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Eng J Med 2001;345:494-502.
25. Sandercock P, Gubitz G, Foley P, et al. Antiplatelet therapy for acute ischaemic stroke (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford. Update Software.